Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - NET CHANGE IN CASH
Net Change in Cash CHRS - Coherus BioSciences, Inc.
39.4 M
LAST VALUE
52.23%
2 YEAR CAGR
22.17%
5 YEAR CAGR
4.64%
10 YEAR CAGR